Professor Kenneth S Suslick is the Marvin T Schmidt Research Professor of Chemistry at the University of Illinois, Urbana-Champaign (UIUC). He joined UIUC after completing his BS at Caltech in 1974 and his PhD at Stanford in 1978. Professor Suslick is the recipient of both the Joel H Hildebrand and Nobel Laureate Signature Awards of the American Chemical Society, the Centenary Prize and the Sir George Stokes Medal of the Royal Society of Chemistry, the Materials Research Society Medal, the Helmholtz-Rayleigh Silver Medal of the Acoustical Society of America, the Chemical Pioneer Award of the American Institute of Chemists, and Sloan and Guggenheim Fellowships. He is a Fellow of the National Academy of Inventors, AAAS, ACS, APS, MRS, RSC, and ASA. He was also the George Eastman Professor at the University of Oxford (2018–2019).
Professor Suslick's two major research areas are the chemical effects of ultrasound (which includes nanomaterials synthesis and sonoluminescence) and chemical sensing (specifically, his invention of the optoelectronic nose for the identification of VOCs, toxic gases, etc). He has published more than 420 scientific papers, edited four books, and holds 58 patents and patent applications.
In addition to his academic research, Professor Suslick has had significant entrepreneurial experience. He was the lead consultant for the team that commercialised the first echo contrast agent for medical sonography. He was also the founding consultant for VivoRx and co-inventor of Abraxane™, the predominant delivery system for taxol chemotherapy for breast cancer. He co-founded iSense and Specific Diagnostics located in Silicon Valley, which began the commercialisation of the Suslick group's optoelectronic nose technology.